2013 annual financial data

Xenon Pharmaceuticals 2013 Net margin

Direct answer

Net margin was 43.98%.

Operating income was 9,712,000 USD and net income was 12,032,000 USD.
Operating cash flow was -3,322,000 USD.

Get free Xenon Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
27,356,000 USD
Operating income
9,712,000 USD
Net income
12,032,000 USD
Operating cash flow
-3,322,000 USD